KYNB Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - FibroGen Inc

Watchlist Manager

Watchlist

Price: 6.94 USD

Market Cap: $28.1m

	FibroGen Inc NASDAQ:KYNB	US
W	Wolters Kluwer NV F:WOSB	NL
M	MGM Resorts International DUS:MGG	US
A	Airtel Africa PLC XBER:9AA	UK
	Northern Superior Resources Inc XTSX:SUP	CA

Profitability Summary

FibroGen Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

346%

Strong 3Y Average Gross Margin

113%

Gross Margin is Increasing

83% > 346%

Negative Operating Margin

-1 477%

Negative 3Y Average Operating Margin

-362%

Declining Operating Margin

-271% > -1 477%

Exceptional Net Margin

2 599%

Strong 3Y Average Net Margin

107%

Net Margin is Increasing

-265% > 2 599%

Negative Free Cash Flow Margin

-206%

Negative 3Y Average Free Cash Flow Margin

-229%

Free Cash Flow Margin is Increasing

-208% > -206%

Negative ROE

-165%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-124%

Declining ROIC

-160% > -177%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.